The ratio of the frequencies of IFN-γ+ CD8+ T cells to IFN-γ+TNF-α+ CD8+ T cells was significantly higher after JEV SA14-14-2 immunization compared with WNV infection for JEV S9 and WNV S9 (p<0.05, Mann–Whitney U test) (Fig. 2D). No significant difference in this ratio was detected between the JEV S9 and WNV S9 variants in either JEV SA14-14-2 immunized or WNV-infected mice. Of note, IFN-γ+TNF-α+ CD8+ T cells from WNV-infected mice produced more TNF-α on a per cell basis than those from JEV SA14-14-2 immunized mice, while levels of IFN-γ from this population were similar for JEV

and WNV (Supporting Information Fig. 2). Since JEV SA14-14-2 is an attenuated virus, we used a pathogenic JEV (Beijing strain) to determine if Panobinostat manufacturer differences in cytokine profiles between JEV and WNV www.selleckchem.com/products/PLX-4032.html could be explained on the basis of the pathogenicity of the infecting virus. We infected mice with a low dose (103 pfu – comparable dose to WNV) or high dose (106 pfu – comparable dose to JEV SA14-14-2) of JEV Beijing. Similar to JEV SA14-14-2, infection with either low- or high-dose JEV Beijing induced a significantly higher frequency of IFN-γ+ CD8+ T cells than IFN-γ+TNF-α+ CD8+ T cells compared to WNV infection (p<0.05, Mann–Whitney U test) (Fig. 2B and C). These findings

indicate that the infecting virus (JEV versus WNV) determined the altered cytokine profile. To ascertain whether the differences in the cytokine profiles are related to different

CD8+ T-cell kinetics, we measured epitope-specific dimer+ CD8+ T cells 5, 7 and 10 days post-infection. Rapid expansion of CD44hidimer+ CD8+ T cells occurred between days 5 and 7 with peak levels occurring at day 7 for all infections with the exception of high-dose JEV Beijing, which peaked at or before day 5 post-infection (Fig. 3 and Supporting Information Fig. 3A). For JEV SA14-14-2 and low-dose JEV Beijing, an approximately four- to eight-fold contraction in frequency and absolute cell number (data not shown) of JEV S9 dimer+ CD8+ T cells occurred between days 7 and 10 while only a one- to two-fold contraction in frequency and absolute cell number (data not shown) of WNV Thalidomide S9 dimer+ CD8+ T cells occurred in WNV-infected mice. Similar to the pattern seen for cytokine production, infection with JEV induced a higher proportion of cross-reactive WNV S9 CD8+ T cells than cross-reactive JEV S9 CD8+ T cells seen in WNV infection. Although the peak CD8+ T-cell response for high-dose JEV Beijing occurred earlier, there was no difference in the frequency of IFN-γ+ and IFN-γ+TNF-α+ CD8+ T cells at day 7 for all JEV infections. These results suggest that the kinetics of epitope-specific cells are not related to the altered cytokine profiles seen. Effector CD8+ T-cell activation depends on many factors, including antigen stimulation and inflammatory conditions 20.